SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017153
Filing Date
2022-11-09
Accepted
2022-11-09 16:11:44
Documents
70
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q omer-20220930x10q.htm   iXBRL 10-Q 1419181
2 EX-10.1 omer-20220930xex10d1.htm EX-10.1 461997
3 EX-31.1 omer-20220930xex31d1.htm EX-31.1 11030
4 EX-31.2 omer-20220930xex31d2.htm EX-31.2 12233
5 EX-32.1 omer-20220930xex32d1.htm EX-32.1 8179
6 EX-32.2 omer-20220930xex32d2.htm EX-32.2 7730
  Complete submission text file 0001558370-22-017153.txt   7070657

Data Files

Seq Description Document Type Size
7 EX-101.SCH omer-20220930.xsd EX-101.SCH 47072
8 EX-101.CAL omer-20220930_cal.xml EX-101.CAL 56383
9 EX-101.DEF omer-20220930_def.xml EX-101.DEF 182998
10 EX-101.LAB omer-20220930_lab.xml EX-101.LAB 405810
11 EX-101.PRE omer-20220930_pre.xml EX-101.PRE 327764
64 EXTRACTED XBRL INSTANCE DOCUMENT omer-20220930x10q_htm.xml XML 1245351
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

IRS No.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34475 | Film No.: 221372693
SIC: 2834 Pharmaceutical Preparations